UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000017640 |
|---|---|
| Receipt number | R000020433 |
| Scientific Title | Patients'characteristic survey concomitantly to the Post Marketing Surveillance(PMS) of Spiriva Respimat |
| Date of disclosure of the study information | 2015/05/22 |
| Last modified on | 2020/08/24 19:46:11 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/05/21 13:46:31 | ||
| 2 | Update | 2015/07/17 17:32:28 | Recruitment status |
|
| 3 | Update | 2016/05/23 08:55:21 | Recruitment status |
|
| 4 | Update | 2016/05/23 08:56:38 | Name of primary person or sponsor Organization |
|
| 5 | Update | 2016/05/23 09:34:07 | Recruitment status |
|
| 6 | Update | 2017/02/21 10:31:59 | Recruitment status Last follow-up date |
|
| 7 | Update | 2017/10/17 17:52:04 | Date trial data considered complete |
|
| 8 | Update | 2018/06/22 09:26:52 | Results Results |
|
| 9 | Update | 2018/06/27 13:26:16 | Date analysis concluded |
|
| 10 | Update | 2018/07/25 13:51:08 | Recruitment status |
|
| 11 | Update | 2018/12/09 08:23:56 | Publication of results URL related to results and publications |
|
| 12 | Update | 2020/08/17 10:59:10 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 13 | Update | 2020/08/17 11:38:16 | URL releasing protocol Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 14 | Update | 2020/08/17 11:44:38 | Date of IRB |
|
| 15 | Update | 2020/08/24 18:57:30 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Last name of contact person Last name of contact person |
|
| 16 | Update | 2020/08/24 19:46:11 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Baseline Characteristics Baseline Characteristics |
